| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.06 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |